Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile; International Physiotherapy Research Network (PhysioEvidence).
Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile; International Physiotherapy Research Network (PhysioEvidence).
Pulmonology. 2021 Jul-Aug;27(4):328-337. doi: 10.1016/j.pulmoe.2020.10.013. Epub 2020 Nov 25.
Evidence suggests lungs as the organ most affected by coronavirus disease 2019 (COVID-19). The literature on previous coronavirus infections reports that patients may experience persistent impairment in respiratory function after being discharged. Our objective was to determine the prevalence of restrictive pattern, obstructive pattern and altered diffusion in patients post-COVID-19 infection and to describe the different evaluations of respiratory function used with these patients.
A systematic review was conducted in five databases. Studies that used lung function testing to assess post-infection COVID-19 patients were included for review. Two independent reviewers analysed the studies, extracted the data and assessed the quality of evidence.
Of the 1973 reports returned by the initial search, seven articles reporting on 380 patients were included in the data synthesis. In the sensitivity analysis, we found a prevalence of 0.39 (CI 0.24-0.56, p < 0.01, I = 86%), 0.15 (CI 0.09-0.22, p = 0.03, I = 59%), and 0.07 (CI 0.04-0.11, p = 0.31, I = 16%) for altered diffusion capacity of the lungs for carbon monoxide (DL), restrictive pattern and obstructive pattern, respectively.
Post-infection COVID-19 patients showed impaired lung function; the most important of the pulmonary function tests affected was the diffusion capacity.
有证据表明,冠状病毒病 2019(COVID-19)对肺部的影响最大。关于以前的冠状病毒感染的文献报告称,患者出院后可能会持续出现呼吸功能受损。我们的目的是确定 COVID-19 感染后患者出现限制性模式、阻塞性模式和弥散功能改变的患病率,并描述对这些患者进行的不同呼吸功能评估。
在五个数据库中进行了系统评价。纳入了使用肺功能测试评估 COVID-19 感染后患者的研究进行综述。两名独立的审查员分析了研究,提取数据并评估证据质量。
在初始搜索返回的 1973 份报告中,有 7 篇文章报道了 380 名患者,纳入了数据综合分析。在敏感性分析中,我们发现弥散功能改变(DL)、限制性模式和阻塞性模式的患病率分别为 0.39(CI 0.24-0.56,p < 0.01,I = 86%)、0.15(CI 0.09-0.22,p = 0.03,I = 59%)和 0.07(CI 0.04-0.11,p = 0.31,I = 16%)。
COVID-19 感染后患者的肺功能受损;受影响最重要的肺功能测试是弥散功能。